This product is a new type of triazole antifungal drug that can specifically and effectively inhibit the synthesis of fungal sterols, that is, the synthesis of ergosterol, the main component of fungal cells. It also inhibits fungal peroxidase, leading to fungal death. Intravenous injection of this product is effective for various animal fungal infections, such as Candida infections (including systemic candidiasis and infections caused by immunosuppression in animals), Cryptococcus neoformans infections (including intracranial infections), Microsporum infections, and Trichophyton, Epidermophyton, Pityrosporum and other infections.

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc. It also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, and gonococci; it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

This product can inhibit the occurrence of cachexia in tumor-bearing mice, inhibit the growth of cancer cells, and prolong the survival time of tumor-bearing mice by more than double. This product can inhibit the production of cachectin in tumor cells, and also inhibit the effect of cachectin on normal cells.

This product is a fluoroquinolone antibiotic that has antibacterial effects on Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, etc.) and some Gram-positive cocci, and has a bactericidal effect by inhibiting bacterial DNA gyrase.